Dobutamine stress echocardiography in orthotopic heart transplant recipients. VACOMED Research Group

Service de Cardiologie, Hopital Charles Nicolle, Centre Hopitalier et Universitaire de Rouen, France.

OBJECTIVES. This study sought to determine whether dobutamine stress echocardiography could accurately identify coronary artery disease after heart transplantation. BACKGROUND. After heart transplantation, coronary artery disease is related to either diffuse concentric intimal thickening or focal stenosis and may be underdiagnosed by coronary angiography. METHODS. We enrolled 41 patients, a mean (+/- SD) of 40 +/- 20 months after heart transplantation, at the time of their routine control coronary angiogram. Three patients were excluded because of poor echogenicity on the angiogram and one because of ventricular premature beats. Standard echocardiographic views were acquired at baseline and at incremental dobutamine infusion levels (from 5 to a maximal dose of 40 micrograms/kg body weight per min at 3-min intervals). Regional wall motion score was calculated from a 16-segment model, and each segment was graded from 1 (normal) to 4 (dyskinesia). Coronary angiography was performed 24 h after dobutamine stress echocardiography, and angiograms were analyzed in blinded manner. RESULTS. Twenty-three (62%) of 37 patients had normal coronary angiographic findings. Dobutamine stress echocardiography showed abnormalities in only 2 of 23 patients. Fourteen patients (38%) had abnormal angiographic findings, seven of whom had stenoses > 50%. Dobutamine stress echocardiography correctly identified the corresponding hypoperfused segments in these seven patients. More of interest were the other seven patients, of whom three had angiographic nonsignificant stenoses (< 50%), and four had minor diffuse coronary irregularities. Dobutamine stress echocardiography showed hypokinesia in five of these seven patients despite nonsignificant lesions at coronary angiography. The respective overall sensitivity and specificity of dobutamine stress echocardiography were 86% and 91%. At follow-up, 2 of the 37 patients had an acute myocardial infarction. Both had abnormal findings on dobutamine stress echocardiography: One had normal coronary angiographic results, and one had significant coronary lesions. CONCLUSIONS. Dobutamine stress echocardiography is a useful technique for the diagnosis of coronary artery disease after heart transplantation. These preliminary results indicate that dobutamine stress echocardiography may have a predictive value for further ischemic events in heart transplant recipients.

This article has been cited by other articles:

				J. D. Estep, D. J. Shah, S. F. Nagueh, J. J. Mahmarian, G. Torre-Amione, and W. A. Zoghbi The Role of Multimodality Cardiac Imaging in the Transplanted Heart J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1126 - 1140. [Abstract] [Full Text] [PDF]

				R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF]

				D. Schmauss and M. Weis Cardiac Allograft Vasculopathy: Recent Developments Circulation, April 22, 2008; 117(16): 2131 - 2141. [Abstract] [Full Text] [PDF]

				E Eroglu, J D'hooge, G R Sutherland, A Marciniak, D Thijs, W Droogne, L Herbots, J Van Cleemput, P Claus, B Bijnens, et al. Quantitative dobutamine stress echocardiography for the early detection of cardiac allograft vasculopathy in heart transplant recipients Heart, February 1, 2008; 94(2): e3 - e3. [Abstract] [Full Text] [PDF]

				J. Jimenez, T. Donahay, L. Schofield, B. A. Khaw, and L. L. Johnson Smooth Muscle Cell Proliferation Index Correlates with 111In-Labeled Antibody Z2D3 Uptake in a Transplant Vasculopathy Swine Model J. Nucl. Med., March 1, 2005; 46(3): 514 - 519. [Abstract] [Full Text] [PDF]

				G.R Ciliberto, L Ruffini, M Mangiavacchi, M Parolini, R Sara, D Massa, R De Maria, E Gronda, E Vitali, and O Parodi Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation Eur. Heart J., June 1, 2001; 22(11): 964 - 971. [Abstract] [PDF]

				K. O. Akosah, B. Denlinger, and P. K. Mohanty Safety Profile and Hemodynamic Responses to {beta}-Adrenergic Stimulation by Dobutamine in Heart Transplant Patients* Chest, December 1, 1999; 116(6): 1587 - 1592. [Abstract] [Full Text] [PDF]

				C. H. Spes, V. Klauss, H. Mudra, S. D. Schnaack, A. R. Tammen, J. Rieber, U. Siebert, K.-H. Henneke, P. Uberfuhr, B. Reichart, et al. Diagnostic and Prognostic Value of Serial Dobutamine Stress Echocardiography for Noninvasive Assessment of Cardiac Allograft Vasculopathy : A Comparison With Coronary Angiography and Intravascular Ultrasound Circulation, August 3, 1999; 100(5): 509 - 515. [Abstract] [Full Text] [PDF]

				P.F. Ludman, F. Lazem, M. Barbir, and M. Yacoub Incidence and clinical relevance of coronary calcification detected by electron beam computed tomography in heart transplant recipients Eur. Heart J., February 2, 1999; 20(4): 303 - 308. [Abstract] [PDF]

				R. L. Larsen, P. M. Applegate, D. A. Dyar, P. A. Ribeiro, S. D. Fritzsche, N. F. Mulla, G. S. Shirali, M. A. Kuhn, R. E. Chinnock, and P. M. Shah Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children J. Am. Coll. Cardiol., August 1, 1998; 32(2): 515 - 520. [Abstract] [Full Text] [PDF]